UnknownPhase 4

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)

Taiwan100 participantsStarted 2009-12

Plain-language summary

Patients with hepatocellular carcinoma and esophageal varices bleeding were randomized to undergo endoscopic ligation alone (group A) and additive propranolol treatment (group B) after stabilization of their first acute bleeding.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. clinical diagnosis of HCC
✓. endoscopically proven acute variceal bleeding
✓. younger than 18 years old or older than 80 years old

Exclusion criteria

✕Had a terminal illness of any major organ system,such as heart failure, kidney failure,COPD

What they're measuring

Rebleeding

Timeframe: 2 year

Trial details

NCT IDNCT01451658

SponsorTaipei Veterans General Hospital, Taiwan

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2020-07-31

View on ClinicalTrials.gov More Gastroesophageal Varices Hemorrhage trials